Clinical Trial Update: Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing three formulations of AGN-210669 ophthalmic solution against Bimatoprost ophthalmic solution for glaucoma (open-angle) and ocular hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• AGN-210669 ophthalmic solution
• Bimatoprost ophthalmic solution (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2013-10-18